SCHEMBL31683263

SCHEMBL31683263

CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 1/20 0.59
▸ GCGR P47871 1/20 0.59
▸ GIPR P48546 1/20 0.59
▸ IL23R Q5VWK5 10/20 0.55
▸ CCKBR P32239 6/20 0.54
▸ ERBB2 P04626 1/20 0.54
▸ KISS1R Q969F8 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30958880 0.90 ERBB2 (0.59) IL23RERBB2KISS1R
SCHEMBL29769338 0.89 IL23R (0.58) IL23RERBB2KISS1R
SCHEMBL30726544 0.88 GLP1R (0.62) GLP1RGCGRGIPRERBB2KISS1R
SCHEMBL30522055 0.88 ERBB2 (0.55) GLP1RGCGRGIPRCCKBRERBB2
SCHEMBL30906347 0.87 GLP1R (0.56) GLP1RGCGRGIPRKISS1R
SCHEMBL30906435 0.87 MAGI3 (0.59) GLP1RGCGRGIPRIL23RKISS1R
SCHEMBL31232401 0.87 GLP1R (0.62) GLP1RGCGRGIPRIL23RCCKBR
SCHEMBL31683350 0.87 CCKBR (0.65) GLP1RGCGRGIPRIL23RCCKBR
SCHEMBL30906578 0.86 GLP1R (0.65) GLP1RGCGRGIPRIL23RKISS1R
SCHEMBL31688336 0.85 IL23R (0.57) IL23RCCKBRERBB2KISS1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250283037-A1 METHODS FOR STIMULATING AND TRANSDUCING T CELLS JUNO THERAPEUTICS GMBH (DE) 2025-09-11 — — US disclosed
Send feedback